Krebs Biochemicals & Industries Limited (BOM:524518)
75.85
+3.10 (4.26%)
At close: Sep 10, 2025
BOM:524518 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Cash & Equivalents | - | 1.42 | 1.37 | 0.86 | 1.01 | 7.11 | Upgrade |
Cash & Short-Term Investments | 1.42 | 1.42 | 1.37 | 0.86 | 1.01 | 7.11 | Upgrade |
Cash Growth | 3.06% | 3.06% | 60.14% | -14.71% | -85.84% | 307.75% | Upgrade |
Accounts Receivable | - | 0.5 | 47.27 | 6.51 | 8.77 | 3 | Upgrade |
Other Receivables | - | 1.74 | 1.67 | 1.36 | 0.97 | 0.77 | Upgrade |
Receivables | - | 2.24 | 48.95 | 7.87 | 9.73 | 3.76 | Upgrade |
Inventory | - | 65.98 | 102.45 | 123.56 | 258.65 | 168.91 | Upgrade |
Prepaid Expenses | - | 4.73 | 3.76 | 5.18 | 4.93 | 3.95 | Upgrade |
Other Current Assets | - | 28.22 | 17.9 | 23.14 | 80.62 | 30.45 | Upgrade |
Total Current Assets | - | 102.59 | 174.42 | 160.61 | 354.93 | 214.18 | Upgrade |
Property, Plant & Equipment | - | 1,465 | 1,495 | 1,487 | 1,442 | 1,264 | Upgrade |
Other Intangible Assets | - | 18.47 | 18.47 | 18.47 | 18.47 | 18.47 | Upgrade |
Long-Term Deferred Charges | - | 4.72 | 6.56 | 8.4 | 10.24 | 16.62 | Upgrade |
Other Long-Term Assets | - | 99.84 | 87.73 | 75.22 | 72.26 | 79.39 | Upgrade |
Total Assets | - | 1,690 | 1,782 | 1,750 | 1,898 | 1,592 | Upgrade |
Accounts Payable | - | 181.53 | 189.7 | 152.81 | 395.47 | 172.46 | Upgrade |
Accrued Expenses | - | 167.94 | 128.61 | 95.29 | 119.75 | 111.97 | Upgrade |
Short-Term Debt | - | 509.58 | 99.3 | 99.9 | 99.86 | 100 | Upgrade |
Current Portion of Long-Term Debt | - | - | 2.47 | 1.34 | 1.83 | 5.92 | Upgrade |
Other Current Liabilities | - | 176.21 | 198.27 | 141.71 | 163.73 | 91.58 | Upgrade |
Total Current Liabilities | - | 1,035 | 618.34 | 491.05 | 780.64 | 481.92 | Upgrade |
Long-Term Debt | - | 1,613 | 1,835 | 1,732 | 1,329 | 1,005 | Upgrade |
Other Long-Term Liabilities | - | 477.3 | 495.01 | 498.03 | 515.73 | 511.52 | Upgrade |
Total Liabilities | - | 3,153 | 2,974 | 2,744 | 2,649 | 2,020 | Upgrade |
Common Stock | - | 215.61 | 215.61 | 215.61 | 215.61 | 196.21 | Upgrade |
Additional Paid-In Capital | - | 1,180 | 1,180 | 1,180 | 1,180 | 1,033 | Upgrade |
Retained Earnings | - | -2,973 | -2,702 | -2,505 | -2,261 | -1,812 | Upgrade |
Comprehensive Income & Other | - | 114.45 | 114.45 | 114.45 | 114.45 | 156.16 | Upgrade |
Shareholders' Equity | -1,462 | -1,462 | -1,192 | -994.62 | -750.93 | -427.33 | Upgrade |
Total Liabilities & Equity | - | 1,690 | 1,782 | 1,750 | 1,898 | 1,592 | Upgrade |
Total Debt | 2,122 | 2,122 | 1,937 | 1,834 | 1,431 | 1,111 | Upgrade |
Net Cash (Debt) | -2,121 | -2,121 | -1,935 | -1,833 | -1,430 | -1,104 | Upgrade |
Net Cash Per Share | -98.31 | -98.36 | -89.77 | -85.01 | -66.32 | -56.28 | Upgrade |
Filing Date Shares Outstanding | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | Upgrade |
Total Common Shares Outstanding | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | 19.62 | Upgrade |
Working Capital | - | -932.67 | -443.92 | -330.44 | -425.71 | -267.75 | Upgrade |
Book Value Per Share | -67.74 | -67.83 | -55.29 | -46.13 | -34.83 | -21.78 | Upgrade |
Tangible Book Value | -1,481 | -1,481 | -1,211 | -1,013 | -769.4 | -445.8 | Upgrade |
Tangible Book Value Per Share | -68.59 | -68.68 | -56.15 | -46.99 | -35.69 | -22.72 | Upgrade |
Land | - | 484.19 | 484.19 | 484.19 | 484.19 | 484.19 | Upgrade |
Buildings | - | 275 | 273.02 | 266.37 | 256.92 | 221.79 | Upgrade |
Machinery | - | 2,350 | 2,335 | 2,248 | 2,106 | 1,871 | Upgrade |
Construction In Progress | - | 12.4 | 1.56 | 22.43 | 65.31 | 100.89 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.